Diverse Recruitment for Clinical Trials Using Three Diversity-Enhancing Interventions: Qualitative Study
JMIR Formative Research · 07.08.2026 · 10 · e86541-e86541
DOI: 10.2196/86541 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift JMIR Formative Research, online erschienen am 07.08.2026. Verfasst von Erin Rose Cruz und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Stanford Medicine, 453 Quarry Rd, Palo Alto, CA, 94304, United States, 1 650-723-2300. Hauptthemen laut MEDLINE: Patient Selection, Clinical Trials as Topic, Cultural Diversity. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: American Heart Association.
Abstract (Originalsprache)
Background
Lack of diversity in clinical trials reduces the generalizability of treatment efficacy across different demographic groups, thereby diminishing the relevance, quality, and equity of research findings.
Objective
This study aimed to evaluate the implementation of 4 recruitment strategies and their impact on clinical trial enrollment through the Trial of Sites to Increase Diversity in Clinical Trials (TOTAL) project, a collaboration between Stanford and Morehouse School of Medicine funded by the American Heart Association.
Methods
Clinical trials were randomized to 1 of 3 recruitment strategy intervention arms (community ambassador, social media ads, or registry and patient engagement platforms) or the control arm (usual recruitment). The Stanford Lightning Report, a rapid qualitative approach, was used to gather insights through interviews with principal investigators (PIs) and trial staff at baseline, 3 months, and trial completion.
Results
Trial teams were supportive of increasing diversity and found the recruitment platforms generally user-friendly. External recruitment support was valued, and some trials reported improved access to participants outside their usual pool. Community ambassadors helped connect trials with community and physician networks and, in some cases, increased recruitment of Asian American participants. Registry and patient engagement platforms were easy to use and supported outreach, including direct emails to potential participants. Social media ads, particularly after the transition to BuildClinical (BuildClinical LLC), improved screening efficiency by prescreening candidates and producing a manageable number of eligible leads. Usual recruitment relied mainly on physician referrals and benefited from trusted clinician-patient relationships, but many trials exhausted their typical participant pools. Across strategies, major barriers included limited time, staff capacity, and financial resources; scarcity of diverse local populations; restrictive eligibility criteria; lack of language access; transportation burdens; and limitations of remote engagement. Additional operational barriers included institutional review board (IRB) delays, contract and vendor approval processes, and platform policy restrictions for digital advertising. Feedback from Lightning Reports led to several real-time changes, including a shift from in-house social media outreach to specialized digital recruitment support.
Conclusions
Increasing diversity in clinical trials requires sustained financial, human, and institutional support, as well as effective recruitment strategies. Rapid qualitative feedback can identify implementation problems early and support real-time improvements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Stanford Medicine, 453 Quarry Rd, Palo Alto, CA, 94304, United States, 1 650-723-2300.
- Morehouse School of Medicine, Atlanta, GA, United States.
- Clinical Trials Postdoctoral Research Fellowship, Strategically Focused Research Network on the Science of Diversity, American Heart Association, Dallas, TX, United States.
ORCID-Profile: Erin Rose Cruz, Tenzin Yeshi Wangdak Yuthok, Anekwe Onwuanyi, Nicholas Vesom, Kira Clark, Phenesse Dunlap, Deidre Amaka Okeke, Farmaan Judge, Victor Ritter, FeiFei Qin, Sa Shen, Anny Rodriguez, Eldrin Lewis, Latha Palaniappan, Cati Brown-Johnson
Förderung
- American Heart Association
Zitieren
APA
Cruz, E. R., Yuthok, T. Y. W., Onwuanyi, A., Vesom, N., Clark, K., Dunlap, P., Okeke, D. A., Judge, F., Ritter, V., Qin, F., Shen, S., Rodriguez, A., Lewis, E., Palaniappan, L., & Brown-Johnson, C. (2026). Diverse Recruitment for Clinical Trials Using Three Diversity-Enhancing Interventions: Qualitative Study. JMIR Formative Research, 10, e86541-e86541. https://doi.org/10.2196/86541
Vancouver
Cruz ER, Yuthok TYW, Onwuanyi A, Vesom N, Clark K, Dunlap P, et al. Diverse Recruitment for Clinical Trials Using Three Diversity-Enhancing Interventions: Qualitative Study. JMIR Formative Research. 2026;10:e86541-e86541. doi:10.2196/86541
BibTeX
@article{Cruz2026,
author = {Cruz, Erin Rose and Yuthok, Tenzin Yeshi Wangdak and Onwuanyi, Anekwe and Vesom, Nicholas and Clark, Kira and Dunlap, Phenesse and Okeke, Deidre Amaka and Judge, Farmaan and Ritter, Victor and Qin, FeiFei and Shen, Sa and Rodriguez, Anny and Lewis, Eldrin and Palaniappan, Latha and Brown-Johnson, Cati},
title = {Diverse Recruitment for Clinical Trials Using Three Diversity-Enhancing Interventions: Qualitative Study},
journal = {JMIR Formative Research},
year = {2026},
volume = {10},
pages = {e86541--e86541},
doi = {10.2196/86541}
}
EUVIMED